Cyclic GMP and regulation of cyclic nucleotide hydrolysis. 
Several of the different PDE isozyme families have the ability in vitro to hydrolyze cGMP.  In particular they include the CaM-dependent PDEs, the cGMP-stimulated PDEs, and the cGMP binding, cGMP-specific PDEs.  Existing evidence suggests or demonstrates that in different cell types, each of these can be important determinants for the control of cGMP steady-state levels.  Each of these enzymes is differentially expressed and regulated; moreover, the amount of the enzyme expressed and the mode of regulation determine to a large extent the rate of rise, maximal level, rate of fall, and duration of the cGMP signal in the cell.  In addition to enzymes that function to degrade cGMP at least two also are regulated by cGMP both in vitro and in the intact cell.  The cGMP-stimulated PDE has the ability to decrease cAMP levels in response to cGMP and the cGMP-inhibited PDE can increase cAMP levels in response to cGMP.  We are just beginning to define how many different isozymes of PDE exist in mammalian tissues, where they are located, and how they are regulated.  Selective inhibitors to each are being developed and studies designed to define structural features that determine the mechanisms of action and regulation of the PDEs have been initiated.  It is expected that in the next few years more PDEs will be discovered and the functions of the new an existing ones with be more clearly defined.